ARCHIVES

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

NCAB Commends Garb for His Contributions

December 11, 1981

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005